Načítá se...

Updated Evaluation of the Safety, Efficacy and Tolerability of Pirfenidone in the Treatment of Idiopathic Pulmonary Fibrosis

Idiopathic Pulmonary Fibrosis (IPF) is a chronic fibrotic disease characterized by a progressive decline in lung function with a median survival of 3–5 years after diagnosis. The course of disease is highly variable and unpredictable, often punctuated by episodes of acute respiratory failure, known...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Healthc Patient Saf
Hlavní autoři: Gulati, Swati, Luckhardt, Tracy R
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove 2020
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7213901/
https://ncbi.nlm.nih.gov/pubmed/32440226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DHPS.S224007
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!